London Health Sciences Center
London, Ontario, N6A 5A5, Canada
NCT Number: NCT03391427
Lidocaine and ketamine both are being used for perioperative analgesia. Perioperative lidocaine infusion has been shown to reduce postoperative pain and opioid consumption. Perioperative low dose Ketamine has shown improved postoperative pain and reduced opioid usage. We therefore tested the hypothesis that the combination would provide better analgesia in the milieu of intrathecal morphine.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
London, Ontario, N6A 5A5, Canada
All study participants were monitored according to American Society of Anesthesiologists guidelines. All received intrathecal morphine (300 to 400 mcg) at L3-4 interspace via 25 G Whitacre needle. Participants were then randomized (computer generated) into one of four groups.
General anesthesia was induced and endotracheal intubation was done. Immediately, after intubation, Lidocaine group (L) received a Lidocaine infusion at 0.33 mg/kg/h.
The Ketamine group (K) received a ketamine infusion at 70 mcg/Kg/h. The Lidocaine-Ketamine group (LK) received a Lidocaine infusion at 0.33 mg/kg/h plus a Ketamine infusion at 70 mcg/Kg/h.
The control group (P) received a normal saline infusion to keep the blind. The infusions were stopped approximately 30-45 minute before the completion of surgery.
All participants received a hydromorphone patient-controlled analgesia (PCA) via a pump. All were given acetaminophen 650 mg every 6 hrs for 4 days.
Postoperatively, participants were monitored for nausea, vomiting, sedation, respiratory depression, light-headedness, perioral numbness, pruritus, disturbed dreams and hallucinations.
Postoperative Hydromorphone consumption for the first, second and third day was recorded from the chart maintained by acute pain service team who were blinded to the group assignment.
After the operation, study participants were interviewed at regular intervals by a blinded investigator about their current pain level, as well as satisfaction with pain management. They were also be questioned regarding the presence and severity of opioid-related side effects (nausea, vomiting, sedation, respiratory depression and, pruritus) and light-headedness, perioral numbness, disturbed dreams and hallucinations. Hospital charts were reviewed and data collected to analyze time to request for additional analgesia and total consumption of opioids, non-opioid analgesics, anti-emetics, and antipruritics within the first 72 hours postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group will receive lidocaine infusion
Other names: Xylocaine, Lidocaine infusion
This group will receive Ketamine infusion
Other names: Ketamine infusion
This group will receive mixture of ketamine and lidocaine infusion
Other names: Lidocaine infusion, Ketamine infusion, Xylocaine
This group will receive saline infusion
Other names: Normal saline
Time frame: 24 hr
Total milligrams of opioids consumed would be measured
Time frame: 48 hrs
Total milligrams of opioids consumed would be measured. Higher opioid consumption indicates worse pain control.
Time frame: 72 hrs
Questions regarding all opioid related side effects will be asked. These will include inquiry regarding nausea, vomiting, hallucinations, sedation, respiratory depression, pruritus
Time frame: 6 weeks
Incidence of chronic pain at 6 weeks will be noted by a numerical rating scale of 1-10 where 0 would be no pain at all and 10 would be worst possible pain. This is standard pain assessment tool. Lower numbers indication better outcomes.
Time frame: 72 hrs
Patient satisfaction will be noted using a numeric rating scale; where 0 will be completely unsatisfied and 10 will be completely satisfied. Higher values depict better satisfaction and better outcomes.
Time frame: 12 weeks
Incidence of chronic pain at 12 weeks will be noted by a numerical rating scale of 1-10 where 0 would be no pain at all and 10 would be worst possible pain. This is standard pain assessment tool. Lower numbers indication better outcomes.
Time frame: 72 hrs
Total milligrams of opioids consumed would be measured. Higher opioid consumption indicates worse pain control.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Ketamine, Lidocaine and Combination for Postoperative Analgesia in Open Liver Resection: A Prospective, Randomized, Four-arm, Double Blind, Placebo Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01469442
Biliary Fistula, Digestive System Diseases
Clichy, France
View Trial DetailsNCT01950845
Colorectal Surgery, Hepatectomy
Pierre-Bénite, France
View Trial DetailsNCT06166186
Fractures, Bone, Fractures, Stress
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07180641
Hepatectomy, Liver Metastases
View Trial Details